Methamphetamine-Quetiapine Interactions in Humans
Methamphetamine-Quetiapine Interaction in Humans: A Pilot Study
Sponsor: University of Arkansas
Terminated
Study was terminated due to insufficient funds
Other terminated trials from University of Arkansas
Other Methamphetamine Dependence trials with similar outcome
Listed as NCT00567866, this EARLY_PHASE1 trial focuses on Methamphetamine Dependence and remains terminated or withdrawn. Sponsored by University of Arkansas, it has been updated 6 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated EARLY_PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Terminated EARLY_PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Terminated EARLY_PHASE1
-
Feb 2017 — Jun 2018 [monthly]
Terminated EARLY_PHASE1
Phase: Phase 0 → EARLY_PHASE1
▶ Show 1 earlier version
-
Jan 2017 — Feb 2017 [monthly]
Terminated Phase 0
First recorded
Jan 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Arkansas
For direct contact, visit the study record on ClinicalTrials.gov .